BIOAVAILABILITY OF 4 BRANDS OF PHENYTOIN

被引：2

作者：

CID, E ^{[1
]}

MORAN, I ^{[1
]}

MONARIS, M ^{[1
]}

LASSERRE, C ^{[1
]}

VIDAL, V ^{[1
]}

机构：

[1] NEUROSURG & BRAIN RES HOSP,SANTIAGO,CHILE

来源：

BIOPHARMACEUTICS & DRUG DISPOSITION | 1981年 / 2卷 / 04期

关键词：

D O I：

10.1002/bdd.2510020408

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：391 / 394

页数：4

共 13 条

[1]

ALBERT KS, 1974, CLIN PHARMACOL THER, V16, P727

[2]

ARNOLD K, 1970, CLIN PHARMACOL THER, V11, P121

[3]

ARNOLD K, 1970, CAN J PHARM SCI, V5, P89

[4]

GLASKO AJ, 1972, PHARMACOLOGY, V8, P163

[5]

GUGLER R, 1976, CLIN PHARMACOL THER, V19, P135

[6] CLINICAL SIGNIFICANCE OF GENERIC INEQUIVALENCE OF 3 DIFFERENT PHARMACEUTICAL PREPARATIONS OF PHENYTOIN [J].

LUND, L .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (02) :119-124

[7] BIOAVAILABILITY OF 11 PHENYTOIN PRODUCTS [J].

MELIKIAN, AP ;

STRAUGHN, AB ;

SLYWKA, GWA ;

WHYATT, PL ;

MEYER, MC .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (02) :133-146

[8]

NEUVONEN PJ, 1977, INT J CLIN PHARM BI, V15, P84

[9] BIOAVAILABILITY OF 4 BRANDS OF PHENYTOIN TABLETS [J].

PENTIKAINEN, PJ ;

NEUVONEN, PJ ;

ELFVING, SM .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (2-3) :213-218

[10]

SAMPSON D, 1971, CLIN CHEM, V17, P382

← 1 2 →